From: Her2 positivity and race predict higher mastectomy rates: a SEER database analysis
T1 | White | Black | Other | T2 | OR (95Â % CI) |
---|---|---|---|---|---|
OR (95Â % CI) | OR (95Â % CI) | OR (95Â % CI) | |||
Her2+/HR+ vs Her2+/HR− | 0.63 (0.57, 0.70) | 0.86 (0.65, 1.13) | 0.61 (0.47, 0.80) | Her2+/HR+ vs Her2+/HR− | 0.66 (0.60, 0.72) |
Her2+/HR+ vs Her2−/HR+ | 1.44 (1.36, 1.53) | 1.30 (1.10, 1.52) | 1.33 (1.12, 1.57) | Her2+/HR+ vs Her2−/HR+ | 1.42 (1.34, 1.50) |
Her2+/HR+Â vs triple negative | 1.20 (1.10, 1.30) | 1.42 (1.16, 1.72) | 1.12 (0.88, 1.44) | Her2+/HR+Â vs triple negative | 1.22 (1.14, 1.32) |
Her2+/HR− vs Her2−/HR+ | 2.28 (2.08, 2.50) | 1.51 (1.19, 1.91) | 2.17 (1.72, 2.74) | Her2+/HR− vs Her2−/HR+ | 2.16 (1.99, 2.34) |
Her2+/HR− vs triple negative | 1.89 (1.69, 2.10) | 1.65 (1.27, 2.14) | 1.84 (1.37, 2.47) | Her2+/HR− vs triple negative | 1.87 (1.70, 2.05) |
Her2−/HR+ vs triple negative | 0.83 (0.78, 0.88) | 1.09 (0.95, 1.26) | 0.85 (0.69, 1.04) | Her2−/HR+ vs triple negative | 0.86 (0.82, 0.91) |